237 related articles for article (PubMed ID: 12600864)
1. Mixed tocopherols inhibit platelet aggregation in humans: potential mechanisms.
Liu M; Wallmon A; Olsson-Mortlock C; Wallin R; Saldeen T
Am J Clin Nutr; 2003 Mar; 77(3):700-6. PubMed ID: 12600864
[TBL] [Abstract][Full Text] [Related]
2. Different isoforms of tocopherols enhance nitric oxide synthase phosphorylation and inhibit human platelet aggregation and lipid peroxidation: implications in therapy with vitamin E.
Li D; Saldeen T; Romeo F; Mehta JL
J Cardiovasc Pharmacol Ther; 2001 Apr; 6(2):155-61. PubMed ID: 11509922
[TBL] [Abstract][Full Text] [Related]
3. Mixed tocopherol preparation is superior to alpha-tocopherol alone against hypoxia-reoxygenation injury.
Chen H; Li D; Saldeen T; Romeo F; Mehta JL
Biochem Biophys Res Commun; 2002 Feb; 291(2):349-53. PubMed ID: 11846411
[TBL] [Abstract][Full Text] [Related]
4. Tocotrienols-induced inhibition of platelet thrombus formation and platelet aggregation in stenosed canine coronary arteries.
Qureshi AA; Karpen CW; Qureshi N; Papasian CJ; Morrison DC; Folts JD
Lipids Health Dis; 2011 Apr; 10():58. PubMed ID: 21489303
[TBL] [Abstract][Full Text] [Related]
5. alpha-Tocopherol and protein kinase C inhibition enhance platelet-derived nitric oxide release.
Freedman JE; Li L; Sauter R; Keaney JF JR
FASEB J; 2000 Dec; 14(15):2377-9. PubMed ID: 11024007
[TBL] [Abstract][Full Text] [Related]
6. Supplementation with mixed tocopherols increases serum and blood cell gamma-tocopherol but does not alter biomarkers of platelet activation in subjects with type 2 diabetes.
Clarke MW; Ward NC; Wu JH; Hodgson JM; Puddey IB; Croft KD
Am J Clin Nutr; 2006 Jan; 83(1):95-102. PubMed ID: 16400056
[TBL] [Abstract][Full Text] [Related]
7. alpha-tocopherol inhibits aggregation of human platelets by a protein kinase C-dependent mechanism.
Freedman JE; Farhat JH; Loscalzo J; Keaney JF
Circulation; 1996 Nov; 94(10):2434-40. PubMed ID: 8921785
[TBL] [Abstract][Full Text] [Related]
8. Select flavonoids and whole juice from purple grapes inhibit platelet function and enhance nitric oxide release.
Freedman JE; Parker C; Li L; Perlman JA; Frei B; Ivanov V; Deak LR; Iafrati MD; Folts JD
Circulation; 2001 Jun; 103(23):2792-8. PubMed ID: 11401934
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneous effects of distinct tocopherol analogues on NO release, cell volume, and cell death in microglial cells.
Sacha B; Zierler S; Lehnardt S; Weber JR; Kerschbaum HH
J Neurosci Res; 2008 Dec; 86(16):3526-35. PubMed ID: 18709655
[TBL] [Abstract][Full Text] [Related]
10. Synthetic byproducts of tocopherol oxidation as inhibitors of platelet function.
Mower R; Steiner M
Prostaglandins; 1982 Aug; 24(2):137-47. PubMed ID: 6815715
[TBL] [Abstract][Full Text] [Related]
11. [Effects of mixed-tocopherols and eicosapentaenoic acid on oxidized LDL-induced oxidative damage and inflammatory cytokine secretion in human umbilical vein endothelial cells].
Xie MB; Liu ML; Huang YS; Li P; Yang YB; Chen XH
Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Mar; 39(3):242-6. PubMed ID: 21609530
[TBL] [Abstract][Full Text] [Related]
12. The activity of constitutive nitric oxide synthase is increased by the pathway cAMP/cAMP-activated protein kinase in human platelets. New insights into the antiaggregating effects of cAMP-elevating agents.
Russo I; Doronzo G; Mattiello L; De Salve A; Trovati M; Anfossi G
Thromb Res; 2004; 114(4):265-73. PubMed ID: 15381390
[TBL] [Abstract][Full Text] [Related]
13. Mixed tocopherols have a stronger inhibitory effect on lipid peroxidation than alpha-tocopherol alone.
Liu M; Wallin R; Wallmon A; Saldeen T
J Cardiovasc Pharmacol; 2002 May; 39(5):714-21. PubMed ID: 11973415
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of alpha- and gamma-tocopherol on low-density lipoprotein oxidation, superoxide activity, platelet aggregation and arterial thrombogenesis.
Saldeen T; Li D; Mehta JL
J Am Coll Cardiol; 1999 Oct; 34(4):1208-15. PubMed ID: 10520814
[TBL] [Abstract][Full Text] [Related]
15. Potentiation of antiaggregating effect of prostaglandins by alpha-tocopherol and quercetin.
Mardla V; Kobzar G; Samel N
Platelets; 2004 Aug; 15(5):319-24. PubMed ID: 15370103
[TBL] [Abstract][Full Text] [Related]
16. Alpha-, gamma- and delta-tocopherols reduce inflammatory angiogenesis in human microvascular endothelial cells.
Wells SR; Jennings MH; Rome C; Hadjivassiliou V; Papas KA; Alexander JS
J Nutr Biochem; 2010 Jul; 21(7):589-97. PubMed ID: 19443199
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of platelet adherence to mononuclear cells by alpha-tocopherol: role of P-selectin.
Murohara T; Ikeda H; Otsuka Y; Aoki M; Haramaki N; Katoh A; Takajo Y; Imaizumi T
Circulation; 2004 Jul; 110(2):141-8. PubMed ID: 15197142
[TBL] [Abstract][Full Text] [Related]
18. Pyridoxine increases nitric oxide biosynthesis in human platelets.
Wu Y; Liu Y; Han Y; Cui B; Mi Q; Huang Y; Wang L; Jiang Q; Chen Q; Liu N; Ferro A; Ji Y
Int J Vitam Nutr Res; 2009 Mar; 79(2):95-103. PubMed ID: 20108211
[TBL] [Abstract][Full Text] [Related]
19. Potent antiplatelet activity of sesamol in an in vitro and in vivo model: pivotal roles of cyclic AMP and p38 mitogen-activated protein kinase.
Chang CC; Lu WJ; Chiang CW; Jayakumar T; Ong ET; Hsiao G; Fong TH; Chou DS; Sheu JR
J Nutr Biochem; 2010 Dec; 21(12):1214-21. PubMed ID: 20015631
[TBL] [Abstract][Full Text] [Related]
20. The role of inhibition of nitric oxide synthesis in the aggregation of platelets due to the stimulated production of thromboxane A2.
Banerjee D; Mazumder S; Sinha AK
Blood Coagul Fibrinolysis; 2014 Sep; 25(6):585-91. PubMed ID: 25083729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
